Researchers Question Process for Reviewing Coverage of 'Off Label' Cancer Drug Use
August 25, 2016
August 25, 2016
CHAPEL HILL, N.C., Aug. 25 -- The University of North Carolina School of Medicine issued the following news:
A group of University of North Carolina Lineberger Comprehensive Cancer Center researchers is calling for an overhaul of the process that determines which cancer drugs used off-label - or beyond their approved use -- are reimbursed by federally-funded health insurance in the United States.
In a paper published online by the Journal of the American Medical Ass . . .
A group of University of North Carolina Lineberger Comprehensive Cancer Center researchers is calling for an overhaul of the process that determines which cancer drugs used off-label - or beyond their approved use -- are reimbursed by federally-funded health insurance in the United States.
In a paper published online by the Journal of the American Medical Ass . . .